Llwytho...
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies
The few therapeutic strategies for advance hepatocellular carcinoma (HCC) on poor knowledge of its biology. For several years, sorafenib, a tyrosine kinase inhibitors (TKI) inhibitor, has been the approved treatment option, to date, for advanced HCC patients. Its activity is the inhibition of the re...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Medicina (Kaunas) |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956203/ https://ncbi.nlm.nih.gov/pubmed/31766556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina55120754 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|